Journal:Cell:1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
IFNs were the first cytokines discovered more than half a century ago as an agent that interfered with viral infection. Since then, IFNs have been established as pleiotropic, multifunctional proteins in the early immune response, exhibiting pronounced antiproliferative effects on cells, in addition to their strong immunomodulatory and antiviral activity. Due to their potency and diverse biological activities, IFNs are used for the treatment of several human diseases, including hepatitis C, multiple sclerosis and certain types of cancer.
IFNs were the first cytokines discovered more than half a century ago as an agent that interfered with viral infection. Since then, IFNs have been established as pleiotropic, multifunctional proteins in the early immune response, exhibiting pronounced antiproliferative effects on cells, in addition to their strong immunomodulatory and antiviral activity. Due to their potency and diverse biological activities, IFNs are used for the treatment of several human diseases, including hepatitis C, multiple sclerosis and certain types of cancer.
-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All <scene name='User:David_Canner/Workbench/Opening_ifna/2'>type I IFNs</scene> initiate signaling by binding to the same receptor composed of two subunits called <scene name='User:David_Canner/Workbench/Opening_ifnar1/3'>IFNAR1</scene> and <scene name='User:David_Canner/Workbench/Opening_ifnar2/2'>IFNAR2</scene>. The intracellular domains (ICDs) of IFNAR1 and IFNAR2 are associated with the Janus kinases (Jaks) Tyk2 and Jak1, respectively (Figure 1A<ref name="Schreiber"> PMID:</ref>). Upon ligand binding by the IFNAR chains and formation of the signaling complex, these tyrosine kinases trans-phosphorylate and thereby activate each other. Subsequently, the activated Jaks phosphorylate STAT1, STAT2 and STAT3, which translocate into the nucleus and activate the transcription of hundreds of IFN-stimulated genes. To gain insight into how type I IFNs engage their receptor chains and how the receptor system is able to recognize the large number of different ligands, we determined the crystal structures of unliganded <scene name='User:David_Canner/Workbench/Opening_ifnar1_alone/2'>IFNAR1 (SD1 through SD3)</scene>, the binary complex <scene name='User:David_Canner/Workbench/Opening_ifnar2_binary/1'>between IFN-alpha-2 and IFNAR2</scene>, and the ternary ligand-receptor complexes of <scene name='User:David_Canner/Workbench/Opening_ternary_alpha/2'>IFN-alpha-2</scene> and <scene name='User:David_Canner/Workbench/Opening_ternary_gamma/3'>IFN-omega</scene> binding both receptor chains (Figure 1C<ref name="Schreiber"/>). A final theoretical ternary structure including <scene name='User:David_Canner/Workbench/Opening_sd4_ternary/1'>IFNAR1-SD4</scene> was also created. These structures, in conjunction with biochemical experiments, reveal that the type I IFN receptor uses a mode of ligand interaction that is unique among cytokine receptors, but conserved between different IFNs.
+
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All <scene name='User:David_Canner/Workbench/Opening_ifna/2'>type I IFNs</scene> initiate signaling by binding to the same receptor composed of two subunits called <scene name='User:David_Canner/Workbench/Opening_ifnar1/3'>IFNAR1</scene> and <scene name='User:David_Canner/Workbench/Opening_ifnar2/2'>IFNAR2</scene>. The intracellular domains (ICDs) of IFNAR1 and IFNAR2 are associated with the Janus kinases (Jaks) Tyk2 and Jak1, respectively (Figure 1A). Upon ligand binding by the IFNAR chains and formation of the signaling complex, these tyrosine kinases trans-phosphorylate and thereby activate each other. Subsequently, the activated Jaks phosphorylate STAT1, STAT2 and STAT3, which translocate into the nucleus and activate the transcription of hundreds of IFN-stimulated genes. To gain insight into how type I IFNs engage their receptor chains and how the receptor system is able to recognize the large number of different ligands, we determined the crystal structures of unliganded <scene name='User:David_Canner/Workbench/Opening_ifnar1_alone/2'>IFNAR1 (SD1 through SD3)</scene>, the binary complex <scene name='User:David_Canner/Workbench/Opening_ifnar2_binary/1'>between IFN-alpha-2 and IFNAR2</scene>, and the ternary ligand-receptor complexes of <scene name='User:David_Canner/Workbench/Opening_ternary_alpha/2'>IFN-alpha-2</scene> and <scene name='User:David_Canner/Workbench/Opening_ternary_gamma/3'>IFN-omega</scene> binding both receptor chains (Figure 1C). A final theoretical ternary structure including <scene name='User:David_Canner/Workbench/Opening_sd4_ternary/1'>IFNAR1-SD4</scene> was also created. These structures, in conjunction with biochemical experiments, reveal that the type I IFN receptor uses a mode of ligand interaction that is unique among cytokine receptors, but conserved between different IFNs.
===Interactions Between IFNAR & IFN===
===Interactions Between IFNAR & IFN===
====IFNAR2-IFN interaction====
====IFNAR2-IFN interaction====
[[Image:Workbench Picture 1.png|300px||right|]]
[[Image:Workbench Picture 1.png|300px||right|]]
-
<scene name='User:David_Canner/Workbench/Opening_ifna/2'>Interferon</scene> interacts primarily with the <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction/1'>D1 domain of IFNAR2</scene>. Arg33IFN appears to be the <scene name='User:David_Canner/Workbench2/Ifn_arg_33/1'>single most important residue</scene> for the interaction of the IFN ligand with IFNAR2 (Figure 3B and D<ref name="Schreiber"> PMID:000000</ref>). It forms an <scene name='User:David_Canner/Workbench2/Ifn_h_bonds_cartoon/2'>extensive hydrogen-bonding network</scene> with the main chain carbonyl oxygen atoms of <scene name='User:David_Canner/Workbench2/Ifn_h_bonds_non_cartoon/3'>Ile45, Lys48, Glu50 and the side chain of Thr44</scene>. This residue is present in IFNα, IFNω, IFNβ and IFNε. Two hydrophobic interaction clusters are present in the <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interact_hydro_full/1'>IFNa-IFNAR2</scene> interface: <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_hydrop1/3'>the first one</scene> is formed between Leu15 and Met16 of the IFN molecule and Trp100 and Ile103 of IFNAR2; Ala19IFN and Met148IFN line this cluster; <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_hydrop2/1'>the second one</scene> comprises Leu26, Phe27, Leu30 and Val142 of the ligand and Met46, Leu52, Val80 and the methyl group of Thr44 of the receptor (Figure 3D<ref name="Schreiber"/>). Replacing <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_leu_30/1'>Leu30IFN with alanine</scene> reduces affinity by three orders of magnitude (the second most important residue for binding). This is surprising, as it is <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_leu_30_nono/4'>not engaged in any intimate contacts with IFNAR2 residues</scene>. One reason for its importance might be a <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_arg_stabilized/1'>stabilizing effect on the position of Arg33IFN</scene>. Furthermore, hydrogen bonds in the <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction_preh/3'>IFNa2-IFNAR2 interface</scene> are observed between <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_h76_hbonds/3'>Ser152IFN and His76R2</scene>, and <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_h76_hbonds2/1'>Arg22IFN and Asn98R2</scene> (Figure 3D<ref name="Schreiber"/>). [[Image:Workbench 3E.png|300px|left|]] Most of the residues involved in the IFNα2-IFNAR2 interaction are also found in the IFNw1-IFNAR2 interface of the IFNω1 ternary complex (Figure 3E<ref name="Schreiber"/>). A significant difference in the IFNAR2 interface between <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction_dif/5'>IFNa2</scene> and IFNω is related to <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction_salt/1'>Arg149 in IFNa2</scene>, which is replaced with Lys152 in <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_structure/3'>IFNw</scene>. In the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar2_interface/3'>IFNw1-IFNAR2 interface</scene>, this residue forms an <scene name='User:David_Canner/Workbench2/Ifnw_ifnar2_salt/1'>intramolecular salt bridge</scene> with Glu147IFN, but <scene name='User:David_Canner/Workbench2/Ifnw_ifnar2_no_interact/1'>does not contact Glu77 of the receptor</scene>. The IFNω1-IFNAR2 interface buries 1820 Å2 of surface area.
+
<scene name='User:David_Canner/Workbench/Opening_ifna/2'>Interferon</scene> interacts primarily with the <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction/1'>D1 domain of IFNAR2</scene>. Arg33IFN appears to be the <scene name='User:David_Canner/Workbench2/Ifn_arg_33/1'>single most important residue</scene> for the interaction of the IFN ligand with IFNAR2 (Figure 3B and D). It forms an <scene name='User:David_Canner/Workbench2/Ifn_h_bonds_cartoon/2'>extensive hydrogen-bonding network</scene> with the main chain carbonyl oxygen atoms of <scene name='User:David_Canner/Workbench2/Ifn_h_bonds_non_cartoon/3'>Ile45, Lys48, Glu50 and the side chain of Thr44</scene>. This residue is present in IFNα, IFNω, IFNβ and IFNε. Two hydrophobic interaction clusters are present in the <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interact_hydro_full/1'>IFNa-IFNAR2</scene> interface: <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_hydrop1/3'>the first one</scene> is formed between Leu15 and Met16 of the IFN molecule and Trp100 and Ile103 of IFNAR2; Ala19IFN and Met148IFN line this cluster; <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_hydrop2/1'>the second one</scene> comprises Leu26, Phe27, Leu30 and Val142 of the ligand and Met46, Leu52, Val80 and the methyl group of Thr44 of the receptor (Figure 3D). Replacing <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_leu_30/1'>Leu30IFN with alanine</scene> reduces affinity by three orders of magnitude (the second most important residue for binding). This is surprising, as it is <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_leu_30_nono/4'>not engaged in any intimate contacts with IFNAR2 residues</scene>. One reason for its importance might be a <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_arg_stabilized/1'>stabilizing effect on the position of Arg33IFN</scene>. Furthermore, hydrogen bonds in the <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction_preh/3'>IFNa2-IFNAR2 interface</scene> are observed between <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_h76_hbonds/3'>Ser152IFN and His76R2</scene>, and <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_h76_hbonds2/1'>Arg22IFN and Asn98R2</scene> (Figure 3D). [[Image:Workbench 3E.png|300px|left|]] Most of the residues involved in the IFNα2-IFNAR2 interaction are also found in the IFNw1-IFNAR2 interface of the IFNω1 ternary complex (Figure 3E). A significant difference in the IFNAR2 interface between <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction_dif/5'>IFNa2</scene> and IFNω is related to <scene name='User:David_Canner/Workbench2/Ifn_ifnar2_interaction_salt/1'>Arg149 in IFNa2</scene>, which is replaced with Lys152 in <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_structure/3'>IFNw</scene>. In the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar2_interface/3'>IFNw1-IFNAR2 interface</scene>, this residue forms an <scene name='User:David_Canner/Workbench2/Ifnw_ifnar2_salt/1'>intramolecular salt bridge</scene> with Glu147IFN, but <scene name='User:David_Canner/Workbench2/Ifnw_ifnar2_no_interact/1'>does not contact Glu77 of the receptor</scene>. The IFNω1-IFNAR2 interface buries 1820 Å2 of surface area.
====IFNAR1-IFN interaction====
====IFNAR1-IFN interaction====
-
Because of the lower resolution of the IFNα ternary complex, we focused on the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_structure/3'>IFNw complex</scene> in our analysis of the IFN-IFNAR1 interface (Figure 4<ref name="Schreiber"/>). However, the IFNω ternary complex <scene name='User:David_Canner/Workbench2/Alignment_1/2'>superimposes perfectly</scene> on the IFNα2 ternary complex, suggesting similar binding. In the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_structure/3'>IFNw-IFNAR1 complex</scene>, the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_zoomed/1'>ligand-binding site of IFNAR1</scene> only contains one hotspot residue we could experimentally confirm, <scene name='User:David_Canner/Workbench2/W-1-tyr_70/1'>Tyr70R1</scene>. Substituting this residue by alanine reduces the affinity to all tested IFN ligands by more than 20-fold (Table 1). The interaction map for the IFNω/IFNAR1 interface suggests that <scene name='User:David_Canner/Workbench2/W-1-phe_238/2'>Phe238R1 on SD3 is another hotspot residue</scene>. However, the F238A mutant of IFNAR1 could not be produced with sufficient yields for quantitative binding studies. On <scene name='User:David_Canner/Workbench2/Inf_gamma_zoomed/2'>IFNw</scene>, mutation studies have shown that a charge-reversal <scene name='User:David_Canner/Workbench2/Inf_arg_123/4'>mutation of Arg123</scene> (Arg 120 on IFNα) lead to a total loss of activity. [[Image:Workbench 4e2.png|300px||left|]] Indeed, this residue forms a <scene name='User:David_Canner/Workbench2/Inf_arg_123_isalt/1'>salt bridge with Asp132R1</scene> in addition to <scene name='User:David_Canner/Workbench2/Inf_arg_123_int/1'>hydrogen bonds with Thr181R1 and Ser182R1</scene> (Figure 4B and 4E<ref name="Schreiber"/>). Substitution of glutamate for Arg123IFN would lead to electrostatic repulsion with Asp132R1. The low affinity of IFNAR1 for the ligand appears to be functionally relevant, as weak binding to IFNAR1 is conserved between all alpha IFNs. Three amino acid substitutions on IFNα2 at positions His57, Glu58 and Ser61 to AAA or to YNS confer tighter binding to IFNAR1, but leave the affinity to IFNAR2 essentially unaltered.
+
Because of the lower resolution of the IFNα ternary complex, we focused on the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_structure/3'>IFNw complex</scene> in our analysis of the IFN-IFNAR1 interface (Figure 4). However, the IFNω ternary complex <scene name='User:David_Canner/Workbench2/Alignment_1/2'>superimposes perfectly</scene> on the IFNα2 ternary complex, suggesting similar binding. In the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_structure/3'>IFNw-IFNAR1 complex</scene>, the <scene name='User:David_Canner/Workbench2/Ifnw_ifnar21_zoomed/1'>ligand-binding site of IFNAR1</scene> only contains one hotspot residue we could experimentally confirm, <scene name='User:David_Canner/Workbench2/W-1-tyr_70/1'>Tyr70R1</scene>. Substituting this residue by alanine reduces the affinity to all tested IFN ligands by more than 20-fold (Table 1). The interaction map for the IFNω/IFNAR1 interface suggests that <scene name='User:David_Canner/Workbench2/W-1-phe_238/2'>Phe238R1 on SD3 is another hotspot residue</scene>. However, the F238A mutant of IFNAR1 could not be produced with sufficient yields for quantitative binding studies. On <scene name='User:David_Canner/Workbench2/Inf_gamma_zoomed/2'>IFNw</scene>, mutation studies have shown that a charge-reversal <scene name='User:David_Canner/Workbench2/Inf_arg_123/4'>mutation of Arg123</scene> (Arg 120 on IFNα) lead to a total loss of activity. [[Image:Workbench 4e2.png|300px||left|]] Indeed, this residue forms a <scene name='User:David_Canner/Workbench2/Inf_arg_123_isalt/1'>salt bridge with Asp132R1</scene> in addition to <scene name='User:David_Canner/Workbench2/Inf_arg_123_int/1'>hydrogen bonds with Thr181R1 and Ser182R1</scene> (Figure 4B and 4E). Substitution of glutamate for Arg123IFN would lead to electrostatic repulsion with Asp132R1. The low affinity of IFNAR1 for the ligand appears to be functionally relevant, as weak binding to IFNAR1 is conserved between all alpha IFNs. Three amino acid substitutions on IFNα2 at positions His57, Glu58 and Ser61 to AAA or to YNS confer tighter binding to IFNAR1, but leave the affinity to IFNAR2 essentially unaltered.
====Implications for the binding mode of IFNβ====
====Implications for the binding mode of IFNβ====
Line 21: Line 21:
===Structural Movements===
===Structural Movements===
====Structural pertubations upon binding====
====Structural pertubations upon binding====
-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;One of the more controversial aspects of cytokine signalling is whether receptor binding is sufficient to generate activity, or it has to be accompanied by structural pertubations. The type I interferon complex is one of the only cytokine receptor complexes were the structures of all the components making up the biologically active complex were determined to high resolution in their free and bound forms. <scene name='User:David_Canner/Workbench3/Morph_1/6'>A comparison</scene> of the unbound NMR structure with the ternary complex structure of interferon shows a small expansion during complex formation. (Figure S3<ref name="Schreiber"> PMID:000000</ref>).
+
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;One of the more controversial aspects of cytokine signalling is whether receptor binding is sufficient to generate activity, or it has to be accompanied by structural pertubations. The type I interferon complex is one of the only cytokine receptor complexes were the structures of all the components making up the biologically active complex were determined to high resolution in their free and bound forms. <scene name='User:David_Canner/Workbench3/Morph_1/6'>A comparison</scene> of the unbound NMR structure with the ternary complex structure of interferon shows a small expansion during complex formation. (Figure S3).
-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversely, both in IFNAR1 and IFNAR2 undergo major domain movements upon binding. Using the D1 domain as anchor, a <scene name='User:David_Canner/Workbench3/Morph_2/10'>clear outwards movement of the D2 domain</scene> of IFNAR2 upon binding, on a scale of 6-12 Å is observed (comparison of the unbound receptor ([[1n6u]]) with the binary IFNα2-IFNAR2 complex). However, also the superimposition of the IFNα2-IFNAR2 binary complex onto IFN-IFNAR2 in the ternary complexes <scene name='User:David_Canner/Workbench3/Morph3/7'>shows an additional domain movement</scene> of 6-9 Å, and even between the ternary IFNα and IFNω complexes a movement of 3-5 Å is observed (Figure S3<ref name="Schreiber"/>). As D2 is engaged in crystal contacts in all three structures, the large variations in D2 may suggest some flexibility in the hinge of D1 and D2 in IFNAR2. Still, these movements could change the proximity/orientation of the ICDs and associated Jaks within the cell.
+
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversely, both in IFNAR1 and IFNAR2 undergo major domain movements upon binding. Using the D1 domain as anchor, a <scene name='User:David_Canner/Workbench3/Morph_2/10'>clear outwards movement of the D2 domain</scene> of IFNAR2 upon binding, on a scale of 6-12 Å is observed (comparison of the unbound receptor ([[1n6u]]) with the binary IFNα2-IFNAR2 complex). However, also the superimposition of the IFNα2-IFNAR2 binary complex onto IFN-IFNAR2 in the ternary complexes <scene name='User:David_Canner/Workbench3/Morph3/7'>shows an additional domain movement</scene> of 6-9 Å, and even between the ternary IFNα and IFNω complexes a movement of 3-5 Å is observed (Figure S3). As D2 is engaged in crystal contacts in all three structures, the large variations in D2 may suggest some flexibility in the hinge of D1 and D2 in IFNAR2. Still, these movements could change the proximity/orientation of the ICDs and associated Jaks within the cell.
-
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The low affinity binding receptor, IFNAR1 also <scene name='User:David_Canner/Workbench3/Morph_4/4'>undergoes major conformational movements</scene> upon ternary complex formation (Figure S3<ref name="Schreiber"/>). When using D1 as anchor, D3 is moving inwards (closing upon interferon) by ~15 Å. This would generate an even larger movement of the transmembrane proximal D4 domain and the transmembrane helix. The IFNAR1 conformation is very similar when ligated to IFNα2 or IFNω, and is not supported by crystal contacts. Contrary to D3, D4 seems to be highly flexible (even more than D2 of IFNAR2). Interestingly, the only hotspot residue on IFNα2 (Arg 120) as well as Leu 117 make contacts with Tyr 70 on D1 of IFNAR1, which is one of the most important residues on the interferon binding site on IFNAR1. This may suggest that D1 makes a futile encounter complex with interferon, which may develop into a signaling complex upon structural rearrangement of the receptor. This would result in a very signification inwards movement of the intracellular, unstructured domain of IFNAR1, promoting proximity between Jak1 and Tyk2 that is required for reciprocal trans-phosphorylation and phosphorylation of specific tyrosine residues in the intracellular domains of IFNAR1 and IFNAR2. Moreover, one may suggest that the conformational change by itself will be responsible for a reduced binding affinity of IFNAR1 and may slow down the rate of ligand association to IFNAR1 directly from solution. The here proposed mechanism would result in a much tighter control on interferon signalling, as random events of receptor proximity will not be able to overcome the activation energy needed for receptor structural rearrangements, which require specific ligand binding. The overall mechanism of activation may be even more complex, if indeed the D2 domain of IFNAR2 is also moving upon ternary complex formation (as suggested by the structures). In this case, a <scene name='User:David_Canner/Workbench3/Morph_full/3'>concerted movement of both receptors</scene> would be required to form a fruitful reaction complex (Figure S3<ref name="Schreiber"/>).
+
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The low affinity binding receptor, IFNAR1 also <scene name='User:David_Canner/Workbench3/Morph_4/4'>undergoes major conformational movements</scene> upon ternary complex formation (Figure S3). When using D1 as anchor, D3 is moving inwards (closing upon interferon) by ~15 Å. This would generate an even larger movement of the transmembrane proximal D4 domain and the transmembrane helix. The IFNAR1 conformation is very similar when ligated to IFNα2 or IFNω, and is not supported by crystal contacts. Contrary to D3, D4 seems to be highly flexible (even more than D2 of IFNAR2). Interestingly, the only hotspot residue on IFNα2 (Arg 120) as well as Leu 117 make contacts with Tyr 70 on D1 of IFNAR1, which is one of the most important residues on the interferon binding site on IFNAR1. This may suggest that D1 makes a futile encounter complex with interferon, which may develop into a signaling complex upon structural rearrangement of the receptor. This would result in a very signification inwards movement of the intracellular, unstructured domain of IFNAR1, promoting proximity between Jak1 and Tyk2 that is required for reciprocal trans-phosphorylation and phosphorylation of specific tyrosine residues in the intracellular domains of IFNAR1 and IFNAR2. Moreover, one may suggest that the conformational change by itself will be responsible for a reduced binding affinity of IFNAR1 and may slow down the rate of ligand association to IFNAR1 directly from solution. The here proposed mechanism would result in a much tighter control on interferon signalling, as random events of receptor proximity will not be able to overcome the activation energy needed for receptor structural rearrangements, which require specific ligand binding. The overall mechanism of activation may be even more complex, if indeed the D2 domain of IFNAR2 is also moving upon ternary complex formation (as suggested by the structures). In this case, a <scene name='User:David_Canner/Workbench3/Morph_full/3'>concerted movement of both receptors</scene> would be required to form a fruitful reaction complex (Figure S3).
__NOTOC__
__NOTOC__
</StructureSection>
</StructureSection>

Revision as of 07:56, 1 June 2011

Solved Structures of IFNAR1/2/IFN Complexes

Drag the structure with the mouse to rotate
  1. no reference


This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools